ID

22208

Description

Strength and Nutrition Outcomes for Latino Adolescents; ODM derived from: https://clinicaltrials.gov/show/NCT00697580

Lien

https://clinicaltrials.gov/show/NCT00697580

Mots-clés

Versions (1)
  1. 23/05/2017 23/05/2017 -
Téléchargé le

23 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Obesity NCT00697580

Anglais

Eligibility Obesity NCT00697580

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Obesity NCT00697580
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
overweight (age- & sex-specific body mass index ≥ 85th percentile based on cdc bmi growth charts [us department of health and human services, 2000], calculated by epi info software, version 3.3)
Description

Overweight Body mass index | Body mass index Age Specific | Body mass index Gender Specific

Type de données

boolean

Alias
UMLS CUI [1,1]
C0497406
UMLS CUI [1,2]
C1305855
UMLS CUI [2,1]
C1305855
UMLS CUI [2,2]
C0001779
UMLS CUI [2,3]
C0205369
UMLS CUI [3,1]
C1305855
UMLS CUI [3,2]
C0079399
UMLS CUI [3,3]
C0205369
latino (both sets of grandparents must be of latino heritage as defined by self-report; limited to latinos to maintain a homogeneous sample and because latinos are at increased risk of insulin resistance and type 2 diabetes.) if the participant or the parent is unsure of the country of origin of all 4 grandparents they will be excluded from the study. the participants and their families are not asked whether or not their grandparents are undocumented immigrants.
Description

Latinos | Homogeneous Sample Selection | Insulin Resistance Risk Increased | Non-Insulin-Dependent Diabetes Mellitus Risk Increased

Type de données

boolean

Alias
UMLS CUI [1]
C0086528
UMLS CUI [2]
C2348990
UMLS CUI [3,1]
C0021655
UMLS CUI [3,2]
C0035647
UMLS CUI [3,3]
C0205217
UMLS CUI [4,1]
C0011860
UMLS CUI [4,2]
C0035647
UMLS CUI [4,3]
C0205217
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
presently taking medication(s) or diagnosed with any syndrome or disease that could influence dietary intake, exercise ability, body composition and fat distribution, or insulin action and secretion.
Description

Pharmaceutical Preparations Affecting Dietary intake | Pharmaceutical Preparations Affecting Exercise Ability | Pharmaceutical Preparations Affecting Body Composition | Pharmaceutical Preparations Affecting Body Fat Distribution | Pharmaceutical Preparations Affecting Insulin Effect | Pharmaceutical Preparations Affecting insulin secretion | Disease Affecting Dietary intake | Disease Affecting Exercise Ability | Disease Affecting Body Composition | Disease Affecting Body Fat Distribution | Disease Affecting Insulin Effect | Disease Affecting insulin secretion

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C1286104
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0015259
UMLS CUI [2,4]
C0085732
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C0005885
UMLS CUI [4,1]
C0013227
UMLS CUI [4,2]
C0392760
UMLS CUI [4,3]
C0424621
UMLS CUI [5,1]
C0013227
UMLS CUI [5,2]
C0392760
UMLS CUI [5,3]
C0021641
UMLS CUI [5,4]
C1280500
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C0392760
UMLS CUI [6,3]
C1256369
UMLS CUI [7,1]
C0012634
UMLS CUI [7,2]
C0392760
UMLS CUI [7,3]
C1286104
UMLS CUI [8,1]
C0012634
UMLS CUI [8,2]
C0392760
UMLS CUI [8,3]
C0015259
UMLS CUI [8,4]
C0085732
UMLS CUI [9,1]
C0012634
UMLS CUI [9,2]
C0392760
UMLS CUI [9,3]
C0005885
UMLS CUI [10,1]
C0012634
UMLS CUI [10,2]
C0392760
UMLS CUI [10,3]
C0424621
UMLS CUI [11,1]
C0012634
UMLS CUI [11,2]
C0392760
UMLS CUI [11,3]
C0021641
UMLS CUI [11,4]
C1280500
UMLS CUI [12,1]
C0012634
UMLS CUI [12,2]
C0392760
UMLS CUI [12,3]
C1256369
previously diagnosed with any major illness since birth (e.g. severe intrauterine growth retardation, chronic birth asphyxia, cancer).
Description

Illness Major | Severe intrauterine growth retardation | Asphyxia Neonatorum chronic | Malignant Neoplasms

Type de données

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205164
UMLS CUI [2]
C1855843
UMLS CUI [3,1]
C0004045
UMLS CUI [3,2]
C0205191
UMLS CUI [4]
C0006826
children will not be eligible for participation if they have any diagnostic criteria for diabetes including polyuria, polydipsia with or without unexplained weight loss, fasting plasma glucose > 126 mg/dl, or a 2-hour plasma glucose >200 mg/dl during an oral glucose tolerance test. children will also be excluded if they test positive for diabetes-related auto-antibodies, including ica512 and gad. children testing positive for type 2 diabetes will be referred for treatment. children with impaired glucose tolerance (fasting glucose >110 mg/dl or 2-hour glucose >140 mg/dl during an ogtt) and/or conditions associated with insulin resistance (e.g. acanthosis nigricans, hypertension, dyslipidemia, pcos) will be eligible, as long as they are not receiving treatment and meet other eligibility criteria.
Description

Diabetes Mellitus | Polyuria | Polydipsia | Unexplained weight loss | Plasma fasting glucose measurement | Plasma Glucose Measurement 2 Hours | Oral Glucose Tolerance Test | Autoantibodies Diabetes Mellitus Related | ICA512 autoantibody | Glutamic Acid Decarboxylase Antibody | Diabetes Mellitus, Non-Insulin-Dependent | Impaired glucose tolerance | Condition Associated with Insulin Resistance | Acanthosis Nigricans | Hypertensive disease | Dyslipidemias | Polycystic Ovary Syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0011849
UMLS CUI [2]
C0032617
UMLS CUI [3]
C0085602
UMLS CUI [4]
C1828173
UMLS CUI [5]
C0583513
UMLS CUI [6,1]
C0202042
UMLS CUI [6,2]
C1292425
UMLS CUI [7]
C0029161
UMLS CUI [8,1]
C0004358
UMLS CUI [8,2]
C0011849
UMLS CUI [8,3]
C0439849
UMLS CUI [9]
C0382981
UMLS CUI [10]
C0443891
UMLS CUI [11]
C0011860
UMLS CUI [12]
C0271650
UMLS CUI [13,1]
C0348080
UMLS CUI [13,2]
C0332281
UMLS CUI [13,3]
C0021655
UMLS CUI [14]
C0000889
UMLS CUI [15]
C0020538
UMLS CUI [16]
C0242339
UMLS CUI [17]
C0032460
participants who are involved in any weight training, exercise, nutrition, or weight loss program or have been in the past 6 months.
Description

Weight Lifting | Exercise | Feeding and dietary regimes | Weight Reduction Programs

Type de données

boolean

Alias
UMLS CUI [1]
C0043095
UMLS CUI [2]
C0015259
UMLS CUI [3]
C0600072
UMLS CUI [4]
C3179079
participants that do not follow the rules and guidelines of appropriate conduct during participation, i.e., disruptive behavior, derogatory or racist comments, or any acts of physical violence towards study staff or other participants, and use of illegal substances. the principal investigator dr. michael goran will decide if this conduct warrants exclusion or removal from the study.
Description

Protocol Compliance Unwilling | Disruptive Behavior | Physical violence | Illicit drug use

Type de données

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C0558080
UMLS CUI [2]
C0474416
UMLS CUI [3]
C0476480
UMLS CUI [4]
C0281875
pregnancy test comes out positive.
Description

Pregnancy test positive

Type de données

boolean

Alias
UMLS CUI [1]
C0240802
children who live further than 20 miles away from the general clinic research center (gcrc).
Description

Residence Distance Clinic / Center - Research

Type de données

boolean

Alias
UMLS CUI [1,1]
C0237096
UMLS CUI [1,2]
C0012751
UMLS CUI [1,3]
C1552456
we can terminate participation if the child fails to follow the rules and guidelines of appropriate behavior and conduct during participation.
Description

Study Subject Participation Status Compliance behavior Dependent

Type de données

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1321605
UMLS CUI [1,3]
C1701901
Retour au début de la page

Similar models

Eligibility Obesity NCT00697580

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Obesity NCT00697580
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Overweight Body mass index | Body mass index Age Specific | Body mass index Gender Specific
Item
overweight (age- & sex-specific body mass index ≥ 85th percentile based on cdc bmi growth charts [us department of health and human services, 2000], calculated by epi info software, version 3.3)
boolean
C0497406 (UMLS CUI [1,1])
C1305855 (UMLS CUI [1,2])
C1305855 (UMLS CUI [2,1])
C0001779 (UMLS CUI [2,2])
C0205369 (UMLS CUI [2,3])
C1305855 (UMLS CUI [3,1])
C0079399 (UMLS CUI [3,2])
C0205369 (UMLS CUI [3,3])
Latinos | Homogeneous Sample Selection | Insulin Resistance Risk Increased | Non-Insulin-Dependent Diabetes Mellitus Risk Increased
Item
latino (both sets of grandparents must be of latino heritage as defined by self-report; limited to latinos to maintain a homogeneous sample and because latinos are at increased risk of insulin resistance and type 2 diabetes.) if the participant or the parent is unsure of the country of origin of all 4 grandparents they will be excluded from the study. the participants and their families are not asked whether or not their grandparents are undocumented immigrants.
boolean
C0086528 (UMLS CUI [1])
C2348990 (UMLS CUI [2])
C0021655 (UMLS CUI [3,1])
C0035647 (UMLS CUI [3,2])
C0205217 (UMLS CUI [3,3])
C0011860 (UMLS CUI [4,1])
C0035647 (UMLS CUI [4,2])
C0205217 (UMLS CUI [4,3])
Item Group
C0680251 (UMLS CUI)
Pharmaceutical Preparations Affecting Dietary intake | Pharmaceutical Preparations Affecting Exercise Ability | Pharmaceutical Preparations Affecting Body Composition | Pharmaceutical Preparations Affecting Body Fat Distribution | Pharmaceutical Preparations Affecting Insulin Effect | Pharmaceutical Preparations Affecting insulin secretion | Disease Affecting Dietary intake | Disease Affecting Exercise Ability | Disease Affecting Body Composition | Disease Affecting Body Fat Distribution | Disease Affecting Insulin Effect | Disease Affecting insulin secretion
Item
presently taking medication(s) or diagnosed with any syndrome or disease that could influence dietary intake, exercise ability, body composition and fat distribution, or insulin action and secretion.
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C1286104 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0015259 (UMLS CUI [2,3])
C0085732 (UMLS CUI [2,4])
C0013227 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0005885 (UMLS CUI [3,3])
C0013227 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0424621 (UMLS CUI [4,3])
C0013227 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C0021641 (UMLS CUI [5,3])
C1280500 (UMLS CUI [5,4])
C0013227 (UMLS CUI [6,1])
C0392760 (UMLS CUI [6,2])
C1256369 (UMLS CUI [6,3])
C0012634 (UMLS CUI [7,1])
C0392760 (UMLS CUI [7,2])
C1286104 (UMLS CUI [7,3])
C0012634 (UMLS CUI [8,1])
C0392760 (UMLS CUI [8,2])
C0015259 (UMLS CUI [8,3])
C0085732 (UMLS CUI [8,4])
C0012634 (UMLS CUI [9,1])
C0392760 (UMLS CUI [9,2])
C0005885 (UMLS CUI [9,3])
C0012634 (UMLS CUI [10,1])
C0392760 (UMLS CUI [10,2])
C0424621 (UMLS CUI [10,3])
C0012634 (UMLS CUI [11,1])
C0392760 (UMLS CUI [11,2])
C0021641 (UMLS CUI [11,3])
C1280500 (UMLS CUI [11,4])
C0012634 (UMLS CUI [12,1])
C0392760 (UMLS CUI [12,2])
C1256369 (UMLS CUI [12,3])
Illness Major | Severe intrauterine growth retardation | Asphyxia Neonatorum chronic | Malignant Neoplasms
Item
previously diagnosed with any major illness since birth (e.g. severe intrauterine growth retardation, chronic birth asphyxia, cancer).
boolean
C0221423 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C1855843 (UMLS CUI [2])
C0004045 (UMLS CUI [3,1])
C0205191 (UMLS CUI [3,2])
C0006826 (UMLS CUI [4])
Diabetes Mellitus | Polyuria | Polydipsia | Unexplained weight loss | Plasma fasting glucose measurement | Plasma Glucose Measurement 2 Hours | Oral Glucose Tolerance Test | Autoantibodies Diabetes Mellitus Related | ICA512 autoantibody | Glutamic Acid Decarboxylase Antibody | Diabetes Mellitus, Non-Insulin-Dependent | Impaired glucose tolerance | Condition Associated with Insulin Resistance | Acanthosis Nigricans | Hypertensive disease | Dyslipidemias | Polycystic Ovary Syndrome
Item
children will not be eligible for participation if they have any diagnostic criteria for diabetes including polyuria, polydipsia with or without unexplained weight loss, fasting plasma glucose > 126 mg/dl, or a 2-hour plasma glucose >200 mg/dl during an oral glucose tolerance test. children will also be excluded if they test positive for diabetes-related auto-antibodies, including ica512 and gad. children testing positive for type 2 diabetes will be referred for treatment. children with impaired glucose tolerance (fasting glucose >110 mg/dl or 2-hour glucose >140 mg/dl during an ogtt) and/or conditions associated with insulin resistance (e.g. acanthosis nigricans, hypertension, dyslipidemia, pcos) will be eligible, as long as they are not receiving treatment and meet other eligibility criteria.
boolean
C0011849 (UMLS CUI [1])
C0032617 (UMLS CUI [2])
C0085602 (UMLS CUI [3])
C1828173 (UMLS CUI [4])
C0583513 (UMLS CUI [5])
C0202042 (UMLS CUI [6,1])
C1292425 (UMLS CUI [6,2])
C0029161 (UMLS CUI [7])
C0004358 (UMLS CUI [8,1])
C0011849 (UMLS CUI [8,2])
C0439849 (UMLS CUI [8,3])
C0382981 (UMLS CUI [9])
C0443891 (UMLS CUI [10])
C0011860 (UMLS CUI [11])
C0271650 (UMLS CUI [12])
C0348080 (UMLS CUI [13,1])
C0332281 (UMLS CUI [13,2])
C0021655 (UMLS CUI [13,3])
C0000889 (UMLS CUI [14])
C0020538 (UMLS CUI [15])
C0242339 (UMLS CUI [16])
C0032460 (UMLS CUI [17])
Weight Lifting | Exercise | Feeding and dietary regimes | Weight Reduction Programs
Item
participants who are involved in any weight training, exercise, nutrition, or weight loss program or have been in the past 6 months.
boolean
C0043095 (UMLS CUI [1])
C0015259 (UMLS CUI [2])
C0600072 (UMLS CUI [3])
C3179079 (UMLS CUI [4])
Protocol Compliance Unwilling | Disruptive Behavior | Physical violence | Illicit drug use
Item
participants that do not follow the rules and guidelines of appropriate conduct during participation, i.e., disruptive behavior, derogatory or racist comments, or any acts of physical violence towards study staff or other participants, and use of illegal substances. the principal investigator dr. michael goran will decide if this conduct warrants exclusion or removal from the study.
boolean
C0525058 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0474416 (UMLS CUI [2])
C0476480 (UMLS CUI [3])
C0281875 (UMLS CUI [4])
Pregnancy test positive
Item
pregnancy test comes out positive.
boolean
C0240802 (UMLS CUI [1])
Residence Distance Clinic / Center - Research
Item
children who live further than 20 miles away from the general clinic research center (gcrc).
boolean
C0237096 (UMLS CUI [1,1])
C0012751 (UMLS CUI [1,2])
C1552456 (UMLS CUI [1,3])
Study Subject Participation Status Compliance behavior Dependent
Item
we can terminate participation if the child fails to follow the rules and guidelines of appropriate behavior and conduct during participation.
boolean
C2348568 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
C1701901 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial